Kolkata, India

Indrani Sarkar




Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Indrani Sarkar: Innovator in Retroviral Treatment

Introduction

Indrani Sarkar is a notable inventor based in Kolkata, India. She has made significant contributions to the field of biotechnology, particularly in the treatment of retroviral infections. Her innovative approach has the potential to change the landscape of how such infections are managed.

Latest Patents

Indrani Sarkar holds a patent for the "Use of tailored recombinases for the treatment of retroviral infections." This invention focuses on a method for preparing an expression vector that encodes a tailored recombinase. The tailored recombinase is designed to recombine asymmetric target sites within the long terminal repeat (LTR) of proviral DNA of a retrovirus. This method is instrumental in excising the provirus from the genome of a host cell. Furthermore, her invention includes an in vitro method for optimizing the treatment of retroviral infections and the use of tailored recombinases in pharmaceutical compositions aimed at reducing viral load in infected subjects. She has 1 patent to her name.

Career Highlights

Indrani has worked with prestigious institutions such as Technische Universität Dresden and the Max Planck Society for the Advancement of Science. Her work in these organizations has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.

Collaborations

Some of her notable coworkers include Joachim Hauber and Frank Buchholz. Their collaboration has contributed to the advancement of research in retroviral treatments.

Conclusion

Indrani Sarkar's innovative work in the field of retroviral treatment showcases her dedication to advancing medical science. Her patented methods have the potential to significantly impact the treatment of retroviral infections, making her a key figure in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…